Meclizine Hydrochloride Tablet
FDA Label NDC 0904-7376

26 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Meclizine Hydrochloride (NDC 0904-7376). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 recommended dosage, 2.2 administration instructions, 3 dosage forms and strengths, 4 contraindications, 5.1 drowsiness, 5.2 concurrent medical conditions, 6 adverse reactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7375-61

Unit Dose

Meclizine Hydrochloride

Tablets, USP

12.5 mg*

100 TABLETS (10 x 10)

Rx only

12.5mg Carton Label (D4732fb5 Fb04 4933 8ecc 98ab55184b54 01)

12.5mg Carton Label (D4732fb5 Fb04 4933 8ecc 98ab55184b54 01)

MAJOR®

NDC 0904-7376-61

Unit Dose

Meclizine Hydrochloride

Tablets, USP

25 mg*

100 TABLETS (10 x 10)

Rx only

25mg Carton Label (D4732fb5 Fb04 4933 8ecc 98ab55184b54 00)

25mg Carton Label (D4732fb5 Fb04 4933 8ecc 98ab55184b54 00)

* Please review the disclaimer below.